CHRISTINA M AVDOULOS

Physician Assistants & Advanced Practice Nursing Providers|Physician Assistant|Medical BAY SHORE, NY NPI 1609816784

General Payments — all program years on this page

$1,687.03

  • Category: General Payments
  • Program years: PY2021–2024
  • Record count: 61
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $514.90 across 21 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $514.9021

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2021 $564.0821
2022 $219.965
2023 $388.0914
2024 $514.9021

Records — PY2024 (21)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1078118102 Janssen Pharmaceuticals, Inc $23.56 03/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1078118254 Janssen Pharmaceuticals, Inc $20.43 03/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1086708103 Novartis Pharmaceuticals Corporation $17.79 01/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1086708107 Novartis Pharmaceuticals Corporation $21.45 01/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1086708131 Novartis Pharmaceuticals Corporation $18.94 08/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1086708135 Novartis Pharmaceuticals Corporation $20.74 08/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1086708149 Novartis Pharmaceuticals Corporation $18.29 11/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1100331532 Novo Nordisk Inc $20.88 05/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1100582720 Novo Nordisk Inc $20.57 02/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1100654823 Novo Nordisk Inc $16.41 08/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1101846031 E.R. Squibb & Sons, L.L.C. $21.68 04/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1101846035 E.R. Squibb & Sons, L.L.C. $17.80 04/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1115432441 Amgen Inc. $13.31 03/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1115432446 Amgen Inc. $119.94 02/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1115432450 Amgen Inc. $20.25 11/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1125823483 Alnylam Pharmaceuticals Inc. $24.20 06/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1129461812 Esperion Therapeutics, Inc. $18.89 10/02/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1154888397 Kiniksa Pharmaceuticals International, plc $23.01 02/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1154888455 Kiniksa Pharmaceuticals International, plc $16.43 06/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1154888495 Kiniksa Pharmaceuticals International, plc $22.75 08/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1154888517 Kiniksa Pharmaceuticals International, plc $17.58 10/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.